Artivion, Inc. (AORT)
38.50
+0.42
(+1.10%)
USD |
NYSE |
Feb 27, 16:00
38.50
0.00 (0.00%)
After-Hours: 20:00
Artivion Research and Development Expense (TTM) : 30.99M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Edwards Lifesciences Corp. | 1.079B |
| Pulse Biosciences, Inc. | 44.72M |
| Zimmer Biomet Holdings, Inc. | 458.60M |
| PetVivo Holdings, Inc. | 1.284M |
| Nutriband, Inc. | 2.193M |